Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yok-Ai Que

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
BMJ Open Respiratory Research|April 23, 2022
Frailty assessment for COVID-19 follow-up: a prospective cohort studyIlena Müller, Marco Mancinetti, Anja Renner, et al.
Influenza and Other Respiratory Viruses|November 17, 2022
Higher risk for influenza-associated pulmonary aspergillosis (IAPA) in asthmatic patients: A Swiss multicenter cohort study on IAPA in critically ill influenza patientsFrederike Waldeck, Filippo Boroli, Sandra Zingg, et al.
The European Respiratory Journal|January 9, 2021
Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung studySabina A Guler, Lukas Ebner, Catherine Aubry-Beigelman, et al.
Critical Care (London, England)|April 21, 2021
Serial measurement of pancreatic stone protein for the early detection of sepsis in intensive care unit patients: a prospective multicentric studyJérôme Pugin, Thomas Daix, Jean-Luc Pagani, et al.
International Journal of Antimicrobial Agents|October 24, 2021
Population pharmacokinetics of cefepime in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study)Vesa Cheng, Mohd H Abdul-Aziz, Fay Burrows, et al.
Respiration; International Review of Thoracic Diseases|December 25, 2022
Pulmonary Recovery 12 Months after Non-Severe and Severe COVID-19: The Prospective Swiss COVID-19 Lung StudyAlexandra Lenoir, Andreas Christe, Lukas Ebner, et al.
Swiss Medical Weekly|June 26, 2022
Critical care staffing ratio and outcome of COVID-19 patients requiring intensive care unit admission during the first pandemic wave: a retrospective analysis across Switzerland from the RISC-19-ICU observational cohortMarie-Madlen Jeitziner, André Moser, Pedro D Wendel-Garcia, et al.
European Journal of Epidemiology|February 25, 2023
Prognostic models in COVID-19 infection that predict severity: a systematic reviewChepkoech Buttia, Erand Llanaj, Hamidreza Raeisi-Dehkordi, et al.
Antimicrobial Agents and Chemotherapy|October 11, 2021
Population Pharmacokinetics of Vancomycin in Critically Ill Adult Patients Receiving Extracorporeal Membrane Oxygenation (an ASAP ECMO Study)Vesa Cheng, Mohd H Abdul-Aziz, Fay Burrows, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2021
Population Pharmacokinetics of Piperacillin and Tazobactam in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation: an ASAP ECMO StudyVesa Cheng, Mohd H Abdul-Aziz, Fay Burrows, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
BMJ Open Respiratory Research|April 23, 2022
Frailty assessment for COVID-19 follow-up: a prospective cohort studyIlena Müller, Marco Mancinetti, Anja Renner, et al.
Influenza and Other Respiratory Viruses|November 17, 2022
Higher risk for influenza-associated pulmonary aspergillosis (IAPA) in asthmatic patients: A Swiss multicenter cohort study on IAPA in critically ill influenza patientsFrederike Waldeck, Filippo Boroli, Sandra Zingg, et al.
The European Respiratory Journal|January 9, 2021
Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung studySabina A Guler, Lukas Ebner, Catherine Aubry-Beigelman, et al.
Critical Care (London, England)|April 21, 2021
Serial measurement of pancreatic stone protein for the early detection of sepsis in intensive care unit patients: a prospective multicentric studyJérôme Pugin, Thomas Daix, Jean-Luc Pagani, et al.
International Journal of Antimicrobial Agents|October 24, 2021
Population pharmacokinetics of cefepime in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study)Vesa Cheng, Mohd H Abdul-Aziz, Fay Burrows, et al.
Respiration; International Review of Thoracic Diseases|December 25, 2022
Pulmonary Recovery 12 Months after Non-Severe and Severe COVID-19: The Prospective Swiss COVID-19 Lung StudyAlexandra Lenoir, Andreas Christe, Lukas Ebner, et al.
Swiss Medical Weekly|June 26, 2022
Critical care staffing ratio and outcome of COVID-19 patients requiring intensive care unit admission during the first pandemic wave: a retrospective analysis across Switzerland from the RISC-19-ICU observational cohortMarie-Madlen Jeitziner, André Moser, Pedro D Wendel-Garcia, et al.
European Journal of Epidemiology|February 25, 2023
Prognostic models in COVID-19 infection that predict severity: a systematic reviewChepkoech Buttia, Erand Llanaj, Hamidreza Raeisi-Dehkordi, et al.
Antimicrobial Agents and Chemotherapy|October 11, 2021
Population Pharmacokinetics of Vancomycin in Critically Ill Adult Patients Receiving Extracorporeal Membrane Oxygenation (an ASAP ECMO Study)Vesa Cheng, Mohd H Abdul-Aziz, Fay Burrows, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2021
Population Pharmacokinetics of Piperacillin and Tazobactam in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation: an ASAP ECMO StudyVesa Cheng, Mohd H Abdul-Aziz, Fay Burrows, et al.
Pageof 10